# Hippocampal transcriptome profiling reveals status epilepticus-induced early changes in gene expression mainly implicating in neuroinflammation and immune responses linked to microglial dysfunction

**Authors:** Hui-Ling Tang, Yu Min, Yue-Sheng Long

PMC · DOI: 10.1371/journal.pone.0344387 · 2026-03-20

## TL;DR

This study shows that status epilepticus causes early changes in gene activity in the hippocampus, mainly related to inflammation and immune responses driven by microglial dysfunction.

## Contribution

The study identifies early transcriptional changes in the hippocampus after SE, specifically highlighting microglia-related inflammation and immune responses.

## Key findings

- 366 and 570 differentially expressed genes were identified at 3-hour and 24-hour time points after SE induction.
- SE-24h up-regulated genes were enriched in inflammatory and immune response pathways, including microglia-related functions.
- Genes like Tyrobp, C1qc, and Itgb2 were linked to inflammatory cascades and microglial dysfunction.

## Abstract

Status epilepticus (SE) is a severe type of epileptic seizure and induces molecular and cellular changes in the brain tissues which contribute to neuron injury. Here we used RNA sequencing to determine changes in hippocampal gene expression in pilocarpine-induced SE mice at 3-hour (SE-3h) and 24-hour (SE-24h) time points, a crucial stage of SE-induced brain acute damage. A total of 366 differentially expressed genes (DEGs) were identified from the SE-3h hippocampus and 570 DEGs from the SE-24h hippocampus, and most of them were up-regulated upon SE induction. Bioinformatical analyses showed that, compared to SE-3h up-regulated genes with poor scores in functional and pathway enrichment, the SE-24h up-regulated genes were predominantly enriched in inflammatory and immune response, positive regulation of response to external stimuli and inflammatory response (GO function), and Microglia pathogen phagocytosis pathway and Tyrobp causal network in microglia (WikiPathway). Specifically, a subset of DEGs such as Tyrobp, C1qc, Itgb2, Ncf2, and Nckap1l involved in the two pathways are present in the inflammatory and immune cascades. Therefore, this study delineates early altered transcriptional profiles in the hippocampus after SE, and highlights up-regulation of a subset of genes might be involved in the activation of microglia-mediated inflammatory and immune responses linked to the early pathogenesis of SE-induced brain injury.

## Linked entities

- **Genes:** TYROBP (transmembrane immune signaling adaptor TYROBP) [NCBI Gene 7305], C1QC (complement C1q C chain) [NCBI Gene 714], ITGB2 (integrin subunit beta 2) [NCBI Gene 3689], NCF2 (neutrophil cytosolic factor 2) [NCBI Gene 4688], NCKAP1L (NCK associated protein 1 like) [NCBI Gene 3071]
- **Chemicals:** pilocarpine (PubChem CID 4819)
- **Species:** Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** Ccl2 (C-C motif chemokine ligand 2) [NCBI Gene 20296] {aka HC11, JE, MCAF, MCP-1, MCP1, SMC-CF}, Ccl3 (C-C motif chemokine ligand 3) [NCBI Gene 20302] {aka G0S19-1, LD78alpha, MIP-1alpha, MIP1-(a), MIP1-alpha, Mip1a}, Timp1 (tissue inhibitor of metalloproteinase 1) [NCBI Gene 21857] {aka Clgi, EPA, TIMP-1, TPA-S1, Timp}, COX2 (cytochrome c oxidase subunit II) [NCBI Gene 4513] {aka COII, MTCO2}, Trem2 (triggering receptor expressed on myeloid cells 2) [NCBI Gene 83433] {aka TREM-2, Trem2a, Trem2b, Trem2c}, NCF2 (neutrophil cytosolic factor 2) [NCBI Gene 4688] {aka NCF-2, NOXA2, P67-PHOX, P67PHOX}, Mx1 (MX dynamin-like GTPase 1) [NCBI Gene 17857] {aka Mx, Mx-1}, Ctsc (cathepsin C) [NCBI Gene 13032] {aka CatC, DPP1, DPPI}, Actb (actin, beta) [NCBI Gene 11461] {aka Actx, E430023M04Rik, beta-actin}, C1qa (complement component 1, q subcomponent, alpha polypeptide) [NCBI Gene 12259] {aka Adic, C1q}, Hmgb1 (high mobility group box 1) [NCBI Gene 15289] {aka HMG-1, Hmg1, SBP-1, p30}, Fcgr1 (Fc receptor, IgG, high affinity I) [NCBI Gene 14129] {aka CD64, FcgammaRI, IGGHAFC}, CYBB (cytochrome b-245 beta chain) [NCBI Gene 1536] {aka AMCBX2, CGD, CGDX, GP91-1, GP91-PHOX, GP91PHOX}, Csf1 (colony stimulating factor 1 (macrophage)) [NCBI Gene 12977] {aka BAP025, Csfm, MCSF, Mhdabap25, PG-M-CSF, op}, ITGB2 (integrin subunit beta 2) [NCBI Gene 3689] {aka CD18, LAD, LCAMB, LFA-1, MAC-1, MF17}, Ccl12 (C-C motif chemokine ligand 12) [NCBI Gene 20293] {aka MCP-5, Scya12}, Fgf3 (fibroblast growth factor 3) [NCBI Gene 14174] {aka Fgf-3, Fgf5c, Int-2, Int-P}, Ncf2 (neutrophil cytosolic factor 2) [NCBI Gene 17970] {aka NOXA2, Ncf-2, p67phox}, Tnf (tumor necrosis factor) [NCBI Gene 21926] {aka DIF, TNF-a, TNF-alpha, TNFSF2, TNFalpha, Tnfa}, Atf3 (activating transcription factor 3) [NCBI Gene 11910] {aka LRG-21}, Clec7a (C-type lectin domain family 7, member a) [NCBI Gene 56644] {aka BGR, Clecsf12, beta-GR}, TREM2 (triggering receptor expressed on myeloid cells 2) [NCBI Gene 54209] {aka AD17, PLOSL2, TREM-2, Trem2a, Trem2b, Trem2c}, Gcg (glucagon) [NCBI Gene 14526] {aka GLP-1, Glu, PPG}, Pycard (PYD and CARD domain containing) [NCBI Gene 66824] {aka 9130417A21Rik, Asc, CARD5, TMS-1, TNS1, masc}, Ifi211 (interferon activated gene 211) [NCBI Gene 381308] {aka A730048F03, Ifi205b, Mnda, ifi-205-B}, Ch25h (cholesterol 25-hydroxylase) [NCBI Gene 12642] {aka m25OH}, NCF1 (neutrophil cytosolic factor 1) [NCBI Gene 653361] {aka CGD1, NCF-1, NCF-47K, NCF1A, NOXO2, SH3PXD1A}, Cxcl10 (C-X-C motif chemokine ligand 10) [NCBI Gene 15945] {aka C7, CRG-2, INP10, IP-10, IP10, Ifi10}, Il1b (interleukin 1 beta) [NCBI Gene 16176] {aka IL-1beta, Il-1b}, Inhba (inhibin beta-A) [NCBI Gene 16323], Zbp1 (Z-DNA binding protein 1) [NCBI Gene 58203] {aka 2010010H03Rik, Dai, Dlm1, mZaDLM}, Tlr4 (toll-like receptor 4) [NCBI Gene 21898] {aka Lps, Ly87, Ran/M1, Rasl2-8}, Lyn (Lyn proto-oncogene, Src family tyrosine kinase) [NCBI Gene 17096] {aka Hck-2, p53Lyn, p56Lyn}, Trh (thyrotropin releasing hormone) [NCBI Gene 22044] {aka Pro-TRH, Trf}, Tac1 (tachykinin 1) [NCBI Gene 21333] {aka 4930528L02Rik, NK-1, NK1, Nkna, PPT-A, PPTA}, Itgb2 (integrin beta 2) [NCBI Gene 16414] {aka 2E6, Cd18, LAD, LCAMB, Lfa1, MF17}, C1qc (complement component 1, q subcomponent, C chain) [NCBI Gene 12262] {aka Adib, C1qg, Ciqc}, Ccl7 (C-C motif chemokine ligand 7) [NCBI Gene 20306] {aka MCP-3, Scya7, fic, marc, mcp3}, Tlr2 (toll-like receptor 2) [NCBI Gene 24088] {aka Ly105}, NCKAP1L (NCK associated protein 1 like) [NCBI Gene 3071] {aka HEM1, IMD72}, Krt75 (keratin 75) [NCBI Gene 109052] {aka 4732468K03Rik, K6hf, Krt2-6hf, Krtcap1}, Fcer1g (Fc receptor, IgE, high affinity I, gamma polypeptide) [NCBI Gene 14127] {aka CD23, FcR-gamma, FcR[g], FcRgamma, Fce1g, FcepsilonRI}, TYROBP (transmembrane immune signaling adaptor TYROBP) [NCBI Gene 7305] {aka DAP12, KARAP, PLOSL, PLOSL1}, Tgm1 (transglutaminase 1, K polypeptide) [NCBI Gene 21816] {aka 2310004J08Rik, Tgase1}, Ccl4 (C-C motif chemokine ligand 4) [NCBI Gene 20303] {aka AT744.1, Act-2, MIP-1B, Mip1b, Scya4}, C1QC (complement C1q C chain) [NCBI Gene 714] {aka C1Q-C, C1QD3, C1QG}, Nckap1l (NCK associated protein 1 like) [NCBI Gene 105855] {aka 4930568P13Rik, Hem1, Hemp1}, Tyrobp (TYRO protein tyrosine kinase binding protein) [NCBI Gene 22177] {aka DAP12, KARAP, Ly83}
- **Diseases:** pain (MESH:D010146), cortical (MESH:D054220), cognitive (MESH:D003072), Parkinson's disease (MESH:D010300), behavioral impairments (MESH:D001523), neuroinflammation (MESH:D000090862), mitochondrial dysfunction (MESH:D028361), emotional disturbances (MESH:D014832), neurodegenerative (MESH:D019636), synaptic loss (MESH:D012183), hippocampal damage (MESH:D000092223), neural injury (MESH:D014947), brain acute damage (MESH:D001930), hippocampal atrophy (MESH:D001284), epilepsy (MESH:D004827), neural damage (MESH:D015441), SE (MESH:D013226), executive dysfunction (MESH:D006331), death (MESH:D003643), neurological emergency (MESH:D004630), neurological disorders (MESH:D009461), Alzheimer's disease (MESH:D000544), brain damage (MESH:D001925), neuron injury (MESH:D009410), impaired working memory (MESH:D008569), traumatic brain injury (MESH:D000070642), attention deficits (MESH:D001289), convulsions (MESH:D012640), inflammation (MESH:D007249), neuronal destruction (MESH:D008105), temporal lobe sclerosis (MESH:D004833), brain dysfunctions (MESH:D001927), volume loss (MESH:D016388), Lung fibrosis (MESH:D005355), gliosis (MESH:D005911)
- **Chemicals:** pilocarpine (MESH:D010862), TRIzol (MESH:C411644), captopril (MESH:D002216), atropine methyl nitrate (MESH:C006649), diazepam (MESH:D003975), reactive oxygen species (MESH:D017382), isoflurane (MESH:D007530)
- **Species:** Homo sapiens (human, species) [taxon 9606], Mus musculus (house mouse, species) [taxon 10090]

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC13004355/full.md

---
Source: https://tomesphere.com/paper/PMC13004355